IDF23-0223 Targeting miR-122 and miR-4756 mitigates atherogenic events by upregulating Sestrin2 under high glucose condition
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: A. Rajagopal, S. Venkatesan, M. Balasubramanyam, R.M. Anjana, V. Mohan, N. Manickam Tags: Cardiovascular Disease Source Type: research